{"description":"Adverse events were not monitored/assessed for this trial.","eventGroups":[{"deathsNumAffected":16,"deathsNumAtRisk":101,"description":"Patients undergo bioelectrical impedance phase angle measurement on day 1 of treatment. Patients with AML undergo a second measurement just prior to the nadir marrow. Patients also undergo bioelectrical impedance measurements prior to any invasive procedures (bone marrow biopsy, leukapheresis, PICC line placement, etc.).\n\nbioelectric impedance analysis: Undergo bioelectric impedance analysis","id":"EG000","otherNumAffected":0,"otherNumAtRisk":0,"seriousNumAffected":0,"seriousNumAtRisk":0,"title":"Diagnostic (Bioelectric Impedance Analysis)"}],"frequencyThreshold":"0","timeFrame":"Up to 2 years to assess for survival only"}